Nantahala Capital Management - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2022$412,000
-24.0%
258,957
-13.1%
0.02%
-5.3%
Q4 2021$542,000
-48.1%
297,947
-20.5%
0.02%
-42.4%
Q3 2021$1,045,000
-63.6%
374,730
-60.3%
0.03%
-59.8%
Q2 2021$2,872,000
-31.0%
944,631
-22.2%
0.08%
-32.8%
Q1 2021$4,162,000
-30.6%
1,213,540
-37.0%
0.12%
-34.4%
Q4 2020$5,993,000
-18.1%
1,926,899
-7.0%
0.19%
-17.0%
Q3 2020$7,317,000
-26.2%
2,072,7450.0%0.22%
-25.1%
Q2 2020$9,908,000
+119.6%
2,072,745
+59.0%
0.30%
+76.9%
Q1 2020$4,511,000
-11.2%
1,303,652
+48.3%
0.17%
+7.6%
Q4 2019$5,082,000
+20.9%
879,2000.0%0.16%
+0.6%
Q3 2019$4,203,000
-35.9%
879,2000.0%0.16%
-22.8%
Q2 2019$6,559,000
+1.0%
879,200
+10.6%
0.20%
-0.5%
Q1 2019$6,493,000
+13.9%
794,701
-4.8%
0.20%
+16.0%
Q4 2018$5,699,000
-50.0%
834,401
-0.5%
0.18%
-42.8%
Q3 2018$11,389,000
+29.1%
838,674
+13.2%
0.31%
-14.3%
Q2 2018$8,819,000
+413.0%
741,108
+140.1%
0.36%
+363.6%
Q1 2018$1,719,000
-53.0%
308,628
-22.8%
0.08%
-52.8%
Q4 2017$3,660,000400,0000.16%
Other shareholders

There were no reported owners of GALMED PHARMACEUTICALS LTD in Q2 2021.

NameSharesValueWeighting ↓
View complete list of GALMED PHARMACEUTICALS LTD shareholders